Raymond George McKay MD
Adult Congenital Heart Disease, Interventional Cardiology
Clinical Professor of Medicine, University Conn
Join to view full profile
85 Seymour StSte. 821Hartford, CT 06106
Phone+1 860-545-5061
Fax+1 860-545-3558
Dr. McKay is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Raymond McKay, MD, based in Hartford, CT, specializes in cardiology with subspecialties in interventional cardiology and structural heart disease. He currently serves as the Director of Research for the Hartford HealthCare Heart & Vascularf Institute. He is a graduate of Harvard Medical School, class of 1978, and he is experienced in general cardiology, cardiac critical care, diagnostic and therapeutic cardiac catheterization , TAVR and percutanis mitral valve repair. He has a total of over 500 peer-reviewed articles and abstracts. His recent publications have appeared in respected journals such as Advanced Science, JACC and The American Journal of Cardiology. McKay has participated in clinical trials focusing on the safety and efficacy of different TAVR bioprotheses for aortic stenosis. His accolades include being named a Regional Top Doctor by Castle Connolly and achieving CMS Meaningful Use Stage 1 Certification. He is also a Fellow of the American College of Cardiology.
Education & Training
Harvard Medical SchoolClass of 1978
Certifications & Licensure
CT State Medical License 1988 - 2027
MA State Medical License 1980 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2011, 2013-2014, 2016-2017
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
Publications & Presentations
PubMed
- Effects of PCSK9 inhibitors on coronary atheroma morphology in patients with coronary artery disease treated with statins: a meta-analysis and systematic review.Priyesh Thakurathi, Agnes S Kim, Michael G Nanna, Khagendra Dahal, Shiva S Aryal
American Journal of Preventive Cardiology. 2026-12-01 - Outcomes of single versus double Perclose suture device use after transfemoral transcatheter procedures using large-bore arterial access: A meta-analysis and systemati...Priyesh Thakurathi, JuYong Lee, Michael G Nana, Shrija Thapa, Rupesh Kshetri
Cardiovascular Revascularization Medicine. 2026-08-21 - Early and Intermediate Outcomes of Cavitron Ultrasonic Surgical Aspiration to Treat Mitral Annular Calcification.Wendy Jin, Sabet W Hashim, Raymond G Mckay, Jeff Mather, Susan Collazo
European Journal of Cardio-Thoracic Surgery. 2026-01-06
Press Mentions
Inside Trump’s Supplement Regimen — and What Experts Say You Can Try TooOctober 6th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: